Literature DB >> 9525690

The TAATGARAT motif in the herpes simplex virus immediate-early gene promoters can confer both positive and negative responses to cellular octamer-binding proteins when it is located within the viral genome.

S Thomas1, R S Coffin, P Watts, G Gough, D S Latchman.   

Abstract

The TAATGARAT motif in the herpes simplex virus (HSV) immediate-early (IE) gene promoters plays a key role in their activation by the Oct-1-Vmw65 complex, but its role in mediating inhibitory effects of cellular octamer-binding proteins is less clear. We have used indicator viruses containing reporter constructs with different IE promoters driving a reporter beta-galactosidase gene within the viral genome to investigate this. We showed that deletion of the upstream IE promoter region containing the TAATGARAT motifs abolishes the inhibitory effect of the cellular octamer-binding proteins Oct-2.4 and Oct-2.5 on the viral IE promoter. This inhibitory effect can be restored by addition of a single TAATGARAT motif to the minimal promoter within the viral genome. Hence, the TAATGARAT motif can indeed mediate both positive and negative effects of cellular transcription factors when it is located within the viral genome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525690      PMCID: PMC109867          DOI: 10.1128/JVI.72.4.3495-3500.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.

Authors:  K D Croen; J M Ostrove; L J Dragovic; J E Smialek; S E Straus
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

2.  Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.

Authors:  I MACPHERSON; M STOKER
Journal:  Virology       Date:  1962-02       Impact factor: 3.616

3.  Growth of herpes simplex virus and purification of viral DNA.

Authors:  D S Latchman; L M Kemp
Journal:  Methods Mol Biol       Date:  1992

Review 4.  Current status review: molecular biology of herpes simplex virus latency.

Authors:  D S Latchman
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

5.  Sequences closely related to an immunoglobulin gene promoter/enhancer element occur also upstream of other eukaryotic and of prokaryotic genes.

Authors:  F G Falkner; R Mocikat; H G Zachau
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

6.  The octamer binding protein Oct-2 inhibits transactivation of the herpes simplex virus immediate-early genes by the virion protein Vmw65.

Authors:  K A Lillycrop; J K Estridge; D S Latchman
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

7.  Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein.

Authors:  K A Lillycrop; S J Dawson; J K Estridge; T Gerster; P Matthias; D S Latchman
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

8.  Characterization of the IE110 gene of herpes simplex virus type 1.

Authors:  L J Perry; F J Rixon; R D Everett; M C Frame; D J McGeoch
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

9.  Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors.

Authors:  R S Coffin; M K Howard; D V Cumming; C M Dollery; J McEwan; D M Yellon; M S Marber; A R MacLean; S M Brown; D S Latchman
Journal:  Gene Ther       Date:  1996-07       Impact factor: 5.250

10.  Alternative splicing of the Oct-2 transcription factor RNA is differentially regulated in neuronal cells and B cells and results in protein isoforms with opposite effects on the activity of octamer/TAATGARAT-containing promoters.

Authors:  K A Lillycrop; D S Latchman
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

View more
  5 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.

Authors:  Bindhu Michael; Amrithraj M Nair; Antara Datta; Hajime Hiraragi; Lee Ratner; Michael D Lairmore
Journal:  Virology       Date:  2006-08-04       Impact factor: 3.616

Review 3.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

4.  Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters.

Authors:  W Zhang; J W Nisbet; J T Bartoe; W Ding; M D Lairmore
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix.

Authors:  Dror Kolodkin-Gal; Gideon Zamir; Yair Edden; Eli Pikarsky; Alon Pikarsky; Hillel Haim; Yosef S Haviv; Amos Panet
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.